期刊文献+

WIF-1对人骨肉瘤MG-63细胞中β-catenin表达的作用研究 被引量:4

Effects of WIF-1 on the expression of β-catenin in human osteosarcoma MG-63 cells
原文传递
导出
摘要 目的 WIF-1是Wnt信号通路中最常见抑制因子之一,本实验研究WIF-1对人骨肉瘤MG-63细胞Wnt信号通路中β-catenin表达量的影响。方法细胞培养人骨肉瘤MG-63细胞,0 ng/ml浓度的WIF-1作为空白对照组,分别以0、48、60、80、120 ng/ml浓度的WIF-1刺激MG-63细胞,分别用FQ-PCR及Western blot法从基因水平、蛋白水平测定细胞中β-catenin的表达量;细胞培养人骨肉瘤MG-63细胞,用WIF-1刺激细胞,分别在第0、12、24、48、72、96 h对各组细胞进行计数,观察空白组及WIF-1刺激组细胞数目的变化情况。结果不同浓度(0、48、60、80、120ng/ml)WIF-1刺激下,FQ-PCR法显示β-catenin mRNA的相对表达总量2-ΔΔCT分别为1、0.55±0.30、0.44±0.24、0.35±0.15、0.24±0.21。与空白组相比较,WIF-1刺激下β-catenin mRNA表达量均降低(P<0.05)。随着WIF-1浓度的增加,β-catenin mRNA表达量下降,但组间的抑制作用无明显差别(P>0.05);Western blot法显示β-catenin/β-actin蛋白相对表达量分别为1.40±0.11、0.86±0.10、0.51±0.11、0.45±0.06、0.18±0.03;与空白组相比较,差异有统计学意义(P<0.05);空白组及WIF-1刺激组细胞数目有差异,空白组细胞增殖情况优于WIF-1刺激组。结论 WIF-1可降低人骨肉瘤MG-63细胞Wnt信号通路中β-catenin表达量,并抑制人骨瘤MG-63细胞的增殖。 ObjectiveWIF-1(Wnt inhibitory factor-1) was one of the most common antagonists of wnt signal pathway, this experiment was to study the expression of β-catenin interfered with WIF-1 in human osteosarcoma MG-63 cells.MethodsHuman MG-63 cells interfered with WIF-1 in the concentration of 0 ng/ml,48 ng/ml,60 ng/ml,80 ng/ml,120 ng/ml was cultured, the concentration of 0 ng/ml was considered as the blank group. The expression of β-catenin was retrospectively detected by the methods of real-time fluorescent quantitative polymerase chain reaction(FQ-PCR) and Western blot at the genetic and protein level. Culturing human MG-63 cells, interfered with the same concentration of WIF-1, the quantity of cells was partly noted in the hour of 0, 12, 24, 48, 72, 96 h. The number was compared between in the blank group and experiment group. Results Interfered with different concentrations(0, 48, 60, 80, 120 ng/ml) of WIF-1. It was showed by FQ-PCR that the relative fold-chages ofβ-catenin mRNA was retrospectively recorded as 1, 0.55±0.30, 0.44±0.24, 0.35±0.15, 0.24±0.21. Compared with the blank group, the stimulating groups were all found to have a lower expression(P〈0.05). With the improvement of concentrations of WIF-1, the expressions of β-catenin presents a decreasing trend .However, these was no significant differences in the stimulating groups themselves; Western blot showed us that the relative fold-chages ofβ-catenin/β-actin was separately memorized as 1.40±0.11, 0.86±0.10, 0.51±0.11, 0.45±0.06, 0.18±0.03; compared with the blank group, differences were statistically significant(P〈0.05). Compared with the stimulating group, the blank group was found to have a higher proliferation. ConclusionWIF-1 could decrease the expressions of β-catenin in the canonical wnt signal pathway of human osteosarcoma MG-63 cells and inhibit the proliferation of human osteosarcoma MG-63 cell.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第21期115-118,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 Β连环素 WIF-1 人骨肉瘤MG-63 beta Catenin WIF-1 Human osteosarcoma MG-63 cells
  • 相关文献

参考文献26

  • 1Niswander LM,Kim SY. Stratifying osteosarcoma:minimizing and maximizing therapy[J].{H}Current Oncology Reports,2010.266-270.
  • 2徐万鹏;冯传汉.骨科肿瘤学[M]{H}北京:人民军医出版社,20086-7.
  • 3Meyers PA,Schwartz CL,Krailo MD. Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group[J].{H}Journal of Clinical Oncology,2008.633-638.
  • 4杨迪生,范顺武,陶惠民,叶招明,何荣新.骨肉瘤辅助化疗方案的中、远期疗效观察[J].中华骨科杂志,2000,20(1):35-39. 被引量:27
  • 5Peifer M,Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus[J].{H}SCIENCE,2000.1606-1609.
  • 6Guo Y,Rubin EM,Xie J. Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model[J].{H}Clinical Orthopaedics and Related Research,2008,(466):2039-2045.
  • 7Guo Y,Zi X,Koontz Z. Blocking Wnt/LRP5 signaling by a solublereceptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells[J].{H}Journal of Orthopaedic Research,2007,(25):964-971.
  • 8江黎珠,陈鸿雁.WIF-1与肿瘤关系的研究进展[J].中国癌症杂志,2010,20(4):299-302. 被引量:5
  • 9Geryk-Hall M,Hughes DP. Critical signaling pathways in bone sarcoma:candidates for therapeutic interventions[J].{H}Current Oncology Reports,2009.446-453.
  • 10Miller JR. The Wnts[J].{H}GENOME BIOLOGY,2001.1-15.

二级参考文献57

  • 1夏贤良,杨迪生,范顺武,陈其昕.骨肉瘤的治疗──117例回顾[J].中华骨科杂志,1994,14(2):79-82. 被引量:14
  • 2Hsieh JC,Kodjabachian L,Rebbert ML,et al.A new secreted protein that binds to Wnt proteins and inhibits their activates[J].Nature,1999,398:431-436.
  • 3Liepinsh E,Ba nyai L,Patthy L,et al.NMR Structure of the WIF Domain of the Human Wnt-Inhibitory Factor-1[J].J Mol Biol,2006,357(3):942-950.
  • 4Kawano Y,Kypta R.Secreted antagonists of the Wnt signaling pathway[J].J.Cell Sci,2003,116:2627-2634.
  • 5Patthy L.The WIF module[J].Trends Biochem Sci,2000,25(1):12-13.
  • 6Lu W,Yamamoto V,Ortega B,et al.Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth[J].Cell,2004,119(1):97-108.
  • 7Das AV,Bhattacharya S,Zhao X,et al.The canonical Wnt pathway regulates retinal stem cells/progenitors in concert with Notch signaling[J].Dev Neurosci,2008,30(6):389-409.
  • 8Garcia MI,Ghiani M,Lefort A,et al.LGR5 deficiency deregulates Wnt signaling and leads to precocious paneth cell differentiation in the fetal intestine[J].Dev Biol,2009,331(1):58-67.
  • 9Lamb R,Harrison H,Clarke RB.Mammary development,carcinomas and progesterone:role of Wnt signaling[J].Ernst Schering Found Symp Proc,2007,(1):1-23.
  • 10Hwang YS,Chung BG,Ortmann D,et al.Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11[J].Proc Natl Acad Sci U S A,2009,106(40):16978-16983.

共引文献41

同被引文献59

  • 1张松,孔维佳,王彦君,韩月臣,张丹.5-杂氮-2′-脱氧胞苷对人鼻咽癌裸鼠移植瘤的抑制作用[J].癌症,2005,24(10):1201-1205. 被引量:15
  • 2赵润年,刘晓勇,张亚锋.5-氮-2-脱氧胞苷的研究进展[J].实用医技杂志,2006,13(4):554-556. 被引量:1
  • 3曾恒,陈安民,李锋,方煌,夏仁云.骨肉瘤诱导分化与多药耐药表型的生物学性状比较[J].中国矫形外科杂志,2007,15(13):1019-1022. 被引量:3
  • 4Lv Z,Wang C,Yuan T,et al.Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/p-catenin path- way[J].Oncology reports,2014,31(2):989-994.
  • 5Wang W,Zhao L,Ma Q,et al.The role of the Wnt/p-catenin pathway in the effect of implant topography on MG63 differentiation[J],Bio- materials,2012,33(32):7993-8002.
  • 6Olivares NR,Hyzy S,Wieland M,et al.The roles of Wnt signaling modulators Dickkopf-I(Dkkl)and Dickkopf-2(Dkk2)and cell mat- uration state in osteogenesis on microstructured titanium surfaces[J].Biomaterials,2010,31(8):2015-2024.
  • 7Olivares NR,Hyzy S,Wieland M,et al.The roles of Wnt signaling modulators Dickkopf-I(Dkkl)and Dickkopf-2(Dkk2)and cell mat- uration state in osteogenesis on microstructured titanium surfaces[J].Biomaterials,2010,31(8):2015-2024.
  • 8Dieudonn^ FX,Marion A,Marie PJ,et al.Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitiza- tion to doxorubicin in osteosarcoma cells and bone tumors in mice[J].J Bone MinerRes,2012,27(10):2118-2129.
  • 9Wang W,Zhao L,Wu K,et al.The role of integrin-linked ki-nase/ p-catenin pathway in the enhanced MG63 differentiation by micro/ nano-textured topography[J].Biomaterials,2013,34(3):631-640.
  • 10DiFiore R,Guercio A,Puleio R,et al.Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts[J].Journal of CellularBiochemistry,2012,113(11):3380-3392.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部